Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT (S.E.A.).
West Haven VA Medical Center, CT (S.E.A.).
Circ Cardiovasc Interv. 2022 Aug;15(8):e011768. doi: 10.1161/CIRCINTERVENTIONS.121.011768. Epub 2022 Aug 8.
Women with coronary artery disease are shown to have worse outcomes after percutaneous coronary intervention compared with men; however, less is known about sex-based outcomes following lower extremity peripheral vascular intervention (PVI) for symptomatic peripheral artery disease. The study aims to assess whether female sex is independently associated with periprocedural complications in patients undergoing PVI.
Analysis includes patients undergoing lower extremity PVI from September 2016 to March 2020 from the Vascular Quality Initiative registry. Multivariate logistic regression was used to assess the independent association of female sex with post-PVI complications.
Of the 119 620 patients included, 47 316 (39.6%) were women. Analysis reflected that women were at higher risk of developing access site complications, including any hematoma (odds ratio [OR], 1.45 [1.35-1.57]), hematoma requiring transfusion (OR, 2.24 [1.82-2.76]; <0.001), hematoma requiring surgery (OR, 1.49 [1.19-1.86]; <0.001), pseudoaneurysm (OR, 1.69 [1.39-2.05]; <0.001), and access site occlusion (OR, 1.89 [1.15-3.08]; <0.001). Women also faced higher risks of target lesion dissection (OR, 1.36 [1.26-1.46]; <0.001), above-knee amputation (OR, 1.37 [1.18-1.58]; <0.001), and in-hospital mortality (OR, 1.21 [1.07-1.38]; =0.003).
In a contemporary cohort, women undergoing lower extremity PVI for symptomatic peripheral artery disease were at higher risk than men of developing periprocedural complications, including moderate or severe access site bleeding, above-knee amputation, and in-hospital mortality. This increased risk persisted despite adjustment for differences in baseline patient or procedural characteristics and warrants further investigation.
与男性相比,患有冠状动脉疾病的女性经皮冠状动脉介入治疗后的预后更差;然而,对于因症状性外周动脉疾病而行下肢外周血管介入治疗(PVI)的患者,关于基于性别的结局知之甚少。本研究旨在评估女性性别是否与 PVI 后围手术期并发症独立相关。
本分析纳入了 2016 年 9 月至 2020 年 3 月期间血管质量倡议登记处接受下肢 PVI 的患者。采用多变量逻辑回归评估女性性别与 PVI 后并发症的独立相关性。
在纳入的 119620 例患者中,47316 例(39.6%)为女性。分析表明,女性发生血管入路并发症的风险更高,包括任何血肿(比值比[OR],1.45[1.35-1.57])、需要输血的血肿(OR,2.24[1.82-2.76];<0.001)、需要手术的血肿(OR,1.49[1.19-1.86];<0.001)、假性动脉瘤(OR,1.69[1.39-2.05];<0.001)和血管入路闭塞(OR,1.89[1.15-3.08];<0.001)。女性还面临更高的靶病变夹层(OR,1.36[1.26-1.46];<0.001)、膝上截肢(OR,1.37[1.18-1.58];<0.001)和住院死亡率(OR,1.21[1.07-1.38];=0.003)的风险。
在当代队列中,因症状性外周动脉疾病而行下肢 PVI 的女性与男性相比,发生围手术期并发症(包括中度或重度血管入路出血、膝上截肢和住院死亡率)的风险更高。尽管调整了患者或手术特征的差异,但这种风险仍然存在,需要进一步研究。